Cite
Wang Y, Qiao L, Yang J, et al. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study. Cancer Commun (Lond). 2021;41(12):1373-1386doi: 10.1002/cac2.12233.
Wang, Y., Qiao, L., Yang, J., Li, X., Duan, Y., Liu, J., Chen, S., Li, H., Liu, D., Fang, T., Ma, J., Li, X., Ye, F., Wan, J., Wei, J., Xu, Q., Guo, E., Jin, P., Wu, M., Zhang, L., Xia, Y., Wu, Y., Shao, J., Feng, Y., Zhang, Q., Yang, Z., Chen, G., Zhang, Q., Li, X., Wang, S., Hu, J., Wang, X., Tan, M. P., Takabe, K., Kong, B., Yang, Q., Ma, D., & Gao, Q. (2021). Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study. Cancer communications (London, England), 41(12), 1373-1386. https://doi.org/10.1002/cac2.12233
Wang, Ya, et al. "Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study." Cancer communications (London, England) vol. 41,12 (2021): 1373-1386. doi: https://doi.org/10.1002/cac2.12233
Wang Y, Qiao L, Yang J, Li X, Duan Y, Liu J, Chen S, Li H, Liu D, Fang T, Ma J, Li X, Ye F, Wan J, Wei J, Xu Q, Guo E, Jin P, Wu M, Zhang L, Xia Y, Wu Y, Shao J, Feng Y, Zhang Q, Yang Z, Chen G, Zhang Q, Li X, Wang S, Hu J, Wang X, Tan MP, Takabe K, Kong B, Yang Q, Ma D, Gao Q. Serum semaphorin 4C as a diagnostic biomarker in breast cancer: A multicenter retrospective study. Cancer Commun (Lond). 2021 Dec;41(12):1373-1386. doi: 10.1002/cac2.12233. Epub 2021 Nov 05. PMID: 34738326; PMCID: PMC8696225.
Copy
Download .nbib